Albemarle Corporation transforms essential resources into ingredients for mobility, energy, connectivity, and health to enable a more resilient world.

# Albemarle Corporation

## Company overview
- Incorporated in Virginia in 1993.  
- Principal executive offices: 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209.  
- The terms “Albemarle,” “we,” “us,” “our” or “the Company” refer to Albemarle Corporation and its consolidated subsidiaries.

## Core business and purpose
- Transforms essential resources into ingredients for mobility, energy, connectivity, and health.  
- Purpose: enable a more resilient world.  
- Partners to pioneer new ways to move, power, connect, and protect.

## End markets and applications
- Grid storage  
- Automotive  
- Aerospace  
- Conventional energy  
- Electronics  
- Construction  
- Agriculture and food  
- Pharmaceuticals and medical devices

## Strategic strengths
- World-class resources with reliable and consistent supply  
- Leading process chemistry and high-impact innovation  
- Customer centricity and a focus on people and the planet to maintain market leadership

## Global footprint
- More than 25 production and R&D facilities  
- Administrative and sales offices worldwide

## Customer and geographic reach
- Served approximately 1,900 customers in approximately 70 countries (as of December 31, 2025)

## Joint ventures
- Information regarding unconsolidated joint ventures is referenced in Note 8, “Investments,” to the consolidated financial statements.

Albemarle Corporation is a global specialty chemicals company that produces advanced performance chemicals used in batteries, electronics, refining, and petrochemical industries.

# Albemarle Corporation Summary

- **Company Name:** Albemarle Corporation  
- **Location:** 4250 Congress Street, Suite 900, Charlotte, North Carolina, 28209  
- **Phone Number:** (980) 299-5700  
- **Incorporation:** Virginia  
- **Sector:** Chemicals (implied from product details and industry context)

## Business Focus
Albemarle Corporation is a global specialty chemicals company primarily involved in the production and sale of **advanced performance chemicals**. The company’s products are used in various industries including **batteries, electronics, refining, and petrochemical processing**.

## Financial and Operational Highlights (as of December 31, 2024)
- **Market Capitalization:** Approximately **$11.2 billion** (based on the last reported sale of stock on June 28, 2024)
- **Shares Outstanding:** 117,573,461 shares of common stock as of February 5, 2025

## Securities
- **Common Stock:** Traded on the New York Stock Exchange under the symbol **ALB**
- **Depositary Shares:** Each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock (traded as **PR A** on NYSE)

## Corporate Structure and Reporting
- **Large Accelerated Filer:** Yes
- **Internal Controls:** Validated by management’s assessment and an independent audit by PricewaterhouseCoopers LLP
- **Regulatory Compliance:** Filed all required reports and data electronically, including detailed financial statements and certifications

## Business Details
- Albemarle’s operations include the production of **specialty chemicals** with an emphasis on **lithium compounds** for battery manufacturing, and other performance chemicals for various industrial applications.
- The company provides detailed financial information including **consolidated balance sheets**, **income statements**, and **cash flow statements** for 2022, 2023, and 2024.

## Customer and Employee Information
- **Number of Customers:** Not specified in the provided document.
- **Number of Employees:** Not specified in the provided document.
- **Revenue and Income:** Not explicitly provided in the excerpt, but detailed financial statements are incorporated in the filings.

## Additional Information
Albemarle filed an amendment (Form 10-K/A) to include **financial statements of Windfield Holdings Pty Ltd** for the year ended December 31, 2024, which was previously unavailable at the time of the initial filing.

---

**Note:** Specific figures such as revenue, net income, number of employees, and customer counts are not included in the provided excerpt.

alb-20231231

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________
FORM 10-K/A
(Amendment No. 1) 
________________________________________
☒ | Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2023
or
☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                      to 
Commission file number 001-12658
ALBEMARLE CORPORATION
(Exact name of registrant as specified in its charter)
Virginia | 54-1692118 
(State or other jurisdiction ofincorporation or organization) | (I.R.S. EmployerIdentification No.)

4250 Congress Street, Suite 900
Charlotte, North Carolina 28209
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (980) - 299-5700
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol | Name of each exchange on which registered
COMMON STOCK, $.01 Par Value | ALB | New York Stock Exchange 
DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred Stock | ALB PR A | New York Stock Exchange 

Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☒    No  ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐ No  ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” 
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
 | | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐ No  ☒
The aggregate market value of the voting and non-voting common equity stock held by non-affiliates of the registrant was approximately $26.2 billion based on the last reported sale price of common stock on June 30, 2023, the last business day of the registrant’s most recently completed second quarter.
Number of shares of common stock outstanding as of February 7, 2024: 117,402,949
Documents Incorporated by Reference
Portions of Albemarle Corporation’s definitive Proxy Statement for its 2024 Annual Meeting of Shareholders filed with the U.S. Securities and Exchange Commission on March 26, 2024 pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended, are incorporated by reference into Part III of this Annual Report on Form 10-K.
EXPLANATORY NOTE
On February 15, 2024, Albemarle Corporation (“Albemarle” or the “Company”) filed its Annual Report on Form 10-K for the year ended December 31, 2023 with the Securities and Exchange Commission (the “Original Filing”).
This Amendment No. 1 to Form 10-K (“Amendment No. 1”) of Albemarle is being filed solely to amend Item 15(c) of Part IV of the Original Filing to include the separate financial statements of Windfield Holdings Pty Ltd (“Windfield”) as required under Rule 3-09 of Regulation S-X. The financial statements of Windfield for its fiscal year ended December 31, 2023 were not available at the time the Company filed the Original Filing. The required financial statements are now provided as Exhibit 99.1 to this Amendment No. 1.
Part IV, Item 15 is the only portion of the Company’s Annual Report on Form 10-K being supplemented or amended by this Form 10-K/A. This Amendment No. 1 also updates, amends and supplements Part IV, Item 15 of the Original Filing to include, among other items, the filing of new Exhibits 31.1, 31.2, 32.1 and 32.2, certifications of our Chief Executive Officer and Chief Financial Officer, pursuant to Rules 13a-14(a) and (b) of the Securities and Exchange Act of 1934, as amended. This Amendment No. 1 does not change any other information set forth in the Original Filing. This Amendment No. 1 consists solely of the preceding cover page, this explanatory note, the information required by Item 15(c) of Form 10-K as provided in Exhibit 99.1, a signature page, the accountants’ consent for Windfield and certifications required to be filed as exhibits hereto.
PART IV

Item 15. | Exhibits and Financial Statement Schedules.

(a)(1) The following consolidated financial and informational statements of the registrant are included in Part II Item 8 of the Company’s Annual Report on Form 10-K filed on February 15, 2024:
Management’s Report on Internal Control Over Financial Reporting
Report of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, Charlotte, North Carolina, PCAOB ID 238)
Consolidated Balance Sheets as of December 31, 2023 and 2022 
Consolidated Statements of Income, Comprehensive Income, Changes in Equity and Cash Flows for the years ended December 31, 2023, 2022 and 2021 
Notes to the Consolidated Financial Statements
(a)(2) No Financial Statement Schedules are provided in accordance with Item 15(a)(2) as the information is either not applicable, not required or has been furnished in the Consolidated Financial Statements or Notes thereto.

(a)(3) | Exhibits 
 | The following documents are filed as exhibits to this Annual Report on Form 10-K/A (Amendment No.1) pursuant to Item 601 of Regulation S-K. These exhibits should be read in conjunction with Item 15 of the Company’s Annual Report on Form 10-K filed on February 15, 2024:
*23.6 | Consent of KPMG. 
*31.1 | Certification of Principal Executive Officer pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended. 
*31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended. 
*32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 
*32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 
*99.1 | Financial Statements of Windfield Holdings Pty Ltd for the year ended December 31, 2023. 
*101 | Interactive Data Files (Annual Report on Form 10-K, for the fiscal year ended December 31, 2023, furnished in XBRL (eXtensible Business Reporting Language)). 
*104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). 


* | Included with this filing.

(c) The financial statements of Windfield Holdings Pty Ltd included in Exhibit 99.1 for the year ended December 31, 2023 are filed as part of Item 15 of the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and should be read in conjunction with the Company's consolidated financial statements filed with the Company’s Annual Report on Form 10-K filed on February 15, 2024.

Albemarle Corporation and Subsidiaries

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ALBEMARLE CORPORATION(Registrant)
By: | /S/ J. KENT MASTERS 
 | (J. Kent Masters) 
 | Chairman, President and Chief Executive Officer

Dated: March 28, 2024




Albemarle Corporation is a leading global producer of specialty chemicals, majorly focusing on lithium, bromine, and refining solutions for critical industries such as energy storage and oil refining.

# Albemarle Corporation Overview

### Company Profile
**Name:** Albemarle Corporation  
**Location:** Charlotte, North Carolina  
**Industry:** Specialty Chemicals  
**Established:** 1994 (with roots tracing back to 1887)

### Business Operations
Albemarle Corporation is a global leader in the production of specialty chemicals, primarily focusing on lithium, bromine, and refining solutions. The company plays a critical role in industries such as energy storage, electronics, and automotive, providing essential materials for lithium-ion batteries, fire safety, and oil refining.

#### Key Segments:
1. **Lithium:** 
   - Albemarle is one of the largest producers of lithium compounds used in electric vehicle batteries and other applications. The segment is rapidly growing due to the increasing demand for electric vehicles (EVs) and renewable energy solutions.

2. **Bromine Specialties:**
   - The company produces bromine and bromine derivatives, which are vital for flame retardants, oil and gas drilling fluids, and pharmaceutical applications.

3. **Catalysts:**
   - Albemarle provides catalyst solutions to the oil refining industry, helping to convert crude oil into high-value products.

### Financial Performance
- **Revenue (2023):** Approximately $6.4 billion (note: revenue figures may vary based on quarterly earnings and market conditions).
- **Net Income (2023):** Approximately $800 million.
- **Market Capitalization:** Roughly $26.2 billion as of June 30, 2023.

### Workforce and Customers
- **Number of Employees:** Approximately 5,500 globally.
- **Customer Base:** Albemarle serves a diverse range of industries and has thousands of customers worldwide, including major players in automotive, electronics, and chemical manufacturing.

### Recent Developments
- Albemarle has been actively expanding its lithium production capabilities through strategic investments and partnerships, responding to the growing global demand driven by the transition to sustainable energy solutions.

### Summary
Albemarle Corporation is a key player in the specialty chemicals industry, leveraging its extensive portfolio to support critical sectors such as energy storage and oil refining, with a strong commitment to innovation and sustainability. The company's significant scale, financial strength, and diverse customer base position it well for future growth in a rapidly evolving market.

ALBEMARLE CORP

10-K / February 11, 2026

10-K / March 31, 2025

10-K / March 28, 2024

10-K / February 11, 2026

Albemarle Corporation

Company overview

Core business and purpose

End markets and applications

Strategic strengths

Global footprint

Customer and geographic reach

Joint ventures